| Name | Title | Contact Details |
|---|
Considered the founder of the industry, Genentech, now a member of the Roche Group, has been delivering on the promise of biotechnology for over 35 years. At Genentech, we use human genetic information to discover, develop, manufacture and commercialize medicines to treat patients with serious or life-threatening medical conditions. Today, we are among the world`s leading biotech companies, with multiple products on the market and a promising development pipeline.
BenevolentAI (AMS: BAI) is a leading, clinical-stage AI-enabled drug discovery and development company listed on the Euronext Amsterdam stock exchange.
FogPharma is dedicated to the creation of a new class of medicines that target human disease drivers currently considered `undruggable`.
We are harnessing the power of the immune system to target some of the most challenging solid tumor malignancies.
GRAIL`s mission is to detect cancer early, when it can be cured.